RECRUITING

Cortical Excitability in Cyclic Vomiting Syndrome

Talk to us

Conditions

Cyclic Vomiting Syndrome

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This exploratory study will determine if there are differences in cortical excitability between patients suffering from cyclic vomiting syndrome (CVS) and healthy control subjects, as assessed by a non-invasive method of brain stimulation (Transcranial Magnetic Stimulation, TMS).

Official Title

Cortical Excitability in Cyclic Vomiting Syndrome

Quick Facts

Study Start:2022-05-16
Study Completion:2025-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05256160

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * diagnosis of CVS
  1. * history of CVS (for healthy control population only)
  2. * psychosis or altered cognitive status
  3. * history of head injury, metal in the skull, stroke, or a history of seizures
  4. * implantable devices, such as a pacemaker or nerve stimulator
  5. * current use of the following medications or use of substances which are known to lower the seizure threshold: clozapine (Clozaril), chlorpromazine (Thorazine), amphetamines or methamphetamine, Ecstasy, Ketamine, Angel Dust/PCP, cocaine, or 3 or more alcoholic drinks per day
  6. * pregnancy

Contacts and Locations

Study Contact

Paul HM Kullmann, PhD
CONTACT
412-647-1533
phmk@pitt.edu
David J Levinthal, MD PhD
CONTACT
412-303-0525
levinthald@upmc.edu

Principal Investigator

David J Levinthal, MD PhD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh

Study Locations (Sites)

University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15232
United States

Collaborators and Investigators

Sponsor: University of Pittsburgh

  • David J Levinthal, MD PhD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-16
Study Completion Date2025-06

Study Record Updates

Study Start Date2022-05-16
Study Completion Date2025-06

Terms related to this study

Additional Relevant MeSH Terms

  • Cyclic Vomiting Syndrome